Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$1.80 AUD
Change Today -0.10 / -5.26%
Volume 1.0M
NAN On Other Exchanges
As of 1:10 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

nanosonics ltd (NAN) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/24/15 - A$2.02
52 Week Low
05/30/14 - A$0.74
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NANOSONICS LTD (NAN)

Related News

No related news articles were found.

nanosonics ltd (NAN) Related Businessweek News

No Related Businessweek News Found

nanosonics ltd (NAN) Details

Nanosonics Limited, together with its subsidiaries, is engaged in the research, development, and commercialization of infection control and decontamination products, and related technologies. The company also manufactures and distributes trophon EPR ultrasound probe disinfector, and its associated consumables and accessories for use in the treatment of healthcare-acquired infections. It operates in North America, Australia, New Zealand, Europe, and other countries. The company was incorporated in 2000 and is based in Alexandria, Australia.

Founded in 2000

nanosonics ltd (NAN) Top Compensated Officers

Chief Executive Officer, President, Managing ...
Total Annual Compensation: A$332.8K
Chief Financial Officer and Company Secretary
Total Annual Compensation: A$308.8K
Chief Operations Officer
Total Annual Compensation: A$241.1K
Head of Research, Design and Development
Total Annual Compensation: A$198.6K
Head of Global Support and Services
Total Annual Compensation: A$168.8K
Compensation as of Fiscal Year 2014.

nanosonics ltd (NAN) Key Developments

Nanosonics Limited(ASX:NAN) added to S&P/ASX 300 Index

Nanosonics Limited(ASX:NAN) added to S&P/ASX 300 Index

Nanosonics Limited(ASX:NAN) added to S&P/ASX Small Ordinaries Index

Nanosonics Limited(ASX:NAN) added to S&P/ASX Small Ordinaries Index

Nanosonics Limited Reports Consolidated Earnings Results for the Six Months Ended December 31, 2014

Nanosonics Limited reported consolidated earnings results for the six months ended December 31, 2014. The company reported sales of goods and services of AUD 14,339,000, operating profit of AUD 1,247,000, net profit attributable to owners of parent entity of AUD 1,247,000 or 0.46 per diluted share against sales of goods and services of AUD 9,680,000, operating loss of AUD 3,453,000, net loss attributable to owners of parent entity of AUD 3,482,000 or 1.33 per diluted share a year ago. Net cash used in operating activities was AUD 2,100,000 against AUD 2,289,000 a year ago. Purchase of property, plant and equipment was AUD 412,000 against AUD 339,000 a year ago.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NAN:AU A$1.80 AUD -0.10

NAN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NAN.
View Industry Companies

Industry Analysis


Industry Average

Valuation NAN Industry Range
Price/Earnings 100.0x
Price/Sales 18.0x
Price/Book 21.3x
Price/Cash Flow 235.2x
TEV/Sales 17.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANOSONICS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at